Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line

Journal of Cellular Physiology

Volumn 222, Issue 2, 2010, Pages 401-410

  Chevanne, Marta ^a   Zampieri, Michele ^b,c   Caldini, Riccardo ^a   Rizzo, Angela ^d   Ciccarone, Fabio ^b   Catizone, Angela ^b   D'Angelo, Carmen ^d   Guastafierro, Tiziana ^b,c   Biroccio, Anna ^d   Reale, Anna ^b,c   Zupi, Gabriella ^d   Caiafa, Paola ^b,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Pasteur Institute   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ANTINEOPLASTIC AGENT; CISPLATIN; ENZYME INHIBITOR; N (OXO 5,6 DIHYDROPHENANTHRIDIN 2 YL) N,N DIMETHYLACETAMIDE HYDROCHLORIDE; N-(OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)-N,N-DIMETHYLACETAMIDE HYDROCHLORIDE; PHENANTHRENE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MELANOMA; MITOSIS; PRIORITY JOURNAL; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MICROSCOPY; NUCLEOLUS; PATHOLOGY; TIME; TUMOR CELL LINE;

ACTINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DEATH; CELL LINE, TUMOR; CELL NUCLEOLUS; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MELANOMA; MICROSCOPY, VIDEO; MITOSIS; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; TIME FACTORS;

EID: 73349086580     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21964     Document Type: Article

References (72)

1. Amankwah KS, De Boni U. 1994. Ultrastructural localization of filamentous actin within neuronal interphase nuclei in situ. Exp Cell Res 210:315-325.
2. Ame JC, Spenlehauer C, de Murcia G. 2004. The PARP superfamily. Bioessays 26:882-893.
3. Augustin A, Spenlehauer C, Dumond H, Menissier-De Murcia J, Piel M, Schmit AC, Apiou F, Vonesch JL, Kock M, Bornens M, De Murcia G. 2003. PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression. J Cell Sci 116:1551-1562.
4. Beneke S, Burkle A. 2004. Poly(ADP-ribosyl)ation, PARP, and aging. Sci Aging Knowledge Environ 2004:re9.
5. Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI. 2007. The multifunctional nucleolus. Nat Rev Mol Cell Biol 8:574-585.
6. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. 2004. Cell death by mitotic catastrophe: A molecular definition. Oncogene 23:2825-2837.
7. Chang P, Jacobson MK, Mitchison TJ. 2004. Poly(ADP-ribose) is required for spindle assembly and structure. Nature 432:645-649.
8. Chang W, Dynek JN, Smith S. 2005. NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis. Biochem J 391:177-184.
9. Compton DA. 2005a. Mitosis: PARty time in the spindle. Curr Biol 15:R178-R179.
10. Compton DA. 2005b. Regulation ofmitosis by poly(ADP-ribosyl)ation. Biochem J 391:e5-e6.
11. Corda D, Di Girolamo M. 2003. Functional aspects of protein mono-ADP-ribosylation. EMBO J 22:1953-1958.
12. d'Adda di Fagagna F, Teo SH, Jackson SP. 2004. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev 18:1781-1799.
13. Dantzer F, Ame JC, Schreiber V, Nakamura J, Menissier-de Murcia J, de Murcia G. 2006.
14. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair. Methods Enzymol 409:493-510.
15. Gambi N, Tramontano F, Quesada P. 2008. Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines. Biochem Pharmacol 75:2356-2363.
16. Graziani G, Szabo C. 2005. Clinical perspectives of PARP inhibitors. Pharmacol Res 52:109-118.
17. Haince JF, Rouleau M, Hendzel MJ, Masson JY, Poirier GG. 2005. Targeting poly(ADPribosyl) ation: A promising approach in cancer therapy. Trends Mol Med 11:456-463.
18. Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514.
19. Hall A, Nobes CD. 2000. Rho GTPases: Molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B Biol Sci 355:965-970.
20. Han SI, Ha KS, Kang KI, Kim HD, Kang HS. 2000. Heat shock-induced actin polymerization, SAPK/JNK activation, and heat-shock protein expression are mediated by genistein-sensitive tyrosine kinase(s) in K562 cells. Cell Biol Int 24:447-457.
21. Hassa PO, Haenni SS, Elser M, Hottiger MO. 2006. Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going? Microbiol Mol Biol Rev 70:789-829.
22. Hofmann WA, de Lanerolle P. 2006. Nuclear actin: To polymerize or not to polymerize. J Cell Biol 172:495-496.
23. Jagtap P, Szabo C. 2005. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4:421-440.
24. Klenova E, Ohlsson R. 2005. Poly(ADP-ribosyl)ation and epigenetics. Is CTCF PARt of the plot? Cell Cycle (Georgetown, Tex) 4:96-101.
25. Korzeniewski C, Callewaert DM. 1983. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64:313-320.
26. Kraus WL. 2008. Transcriptional control by PARP-1: Chromatin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol 20:294-302.
27. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M, Kraus WL. 2008. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science (New York, NY) 319:819-821.
28. Malanga M, Althaus FR. 2005. The role of poly(ADP-ribose) in the DNA damage signaling network. Biochem Cell Biol (Biochim Biol Cell) 83:354-364.
29. Malorni W, Rainaldi G, Straface E, Rivabene R, Cossarizza A, Capri M, Monti D, Franceschi C. 1994a. 3-Aminobenzamide induces cytoskeleton rearrangement in M14 melanoma cells. Biochem Biophys Res Commun 202:915-922.
30. Malorni W, Rainaldi G, Straface E, Rivabene R, Cossarizza A, Salvioli S, Monti D, Franceschi C. 1994b. Cell death protection by 3-aminobenzamide: Impairment of cytoskeleton function in human NK cell-mediated killing. Biochem Biophys Res Commun 199:1250-1255.
31. McDonald D, Carrero G, Andrin C, de Vries G, Hendzel MJ. 2006. Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations. J Cell Biol 172:541-552.
32. Meder VS, Boeglin M, de Murcia G, Schreiber V. 2005. PARP-1 and PARP-2 interact with nucleophosmin/B23 and accumulate in transcriptionally active nucleoli. J Cell Sci 118:211-222.
33. Menissier de Murcia J, Ricoul M, Tartier L, Niedergang C, Huber A, Dantzer F, Schreiber V, Ame JC, Dierich A, LeMeur M, Sabatier L, Chambon P, de Murcia G. 2003. Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J 22:2255-2263.
34. Nakayasu H, Ueda K. 1986. Preferential association of acidic actin with nuclei and nuclear matrix from mouse leukemia L5178Y cells. Exp Cell Res 163:327-336.
35. Nguyen E, Besombes D, Debey P. 1998. Immunofluorescent localization of actin in relation to transcription sites in mouse pronuclei. Molecular reproduction and development 50:263-272.
36. Olave IA, Reck-Peterson SL, Crabtree GR. 2002. Nuclear actin and actin-related proteins in chromatin remodeling. Annu Rev Biochem 71:755-781.
37. Parfenov VN, Davis DS, Pochukalina GN, Sample CE, Bugaeva EA, Murti KG. 1995. Nuclear actin filaments and their topological changes in frog oocytes. Exp Cell Res 217:385-394.
38. Pederson T. 2008. As functional nuclear actin comes into view, is it globular, filamentous, or both? J Cell Biol 180:1061-1064.
39. Pederson T, Aebi U. 2002. Actin in the nucleus: What form and what for? J Struct Biol 140:3-9.
40. Pederson T, Aebi U. 2005. Nuclear actin extends, with no contraction in sight. Mol Biol Cell 16:5055-5060.
41. Philimonenko VV, Zhao J, Iben S, Dingova H, Kysela K, Kahle M, Zentgraf H, Hofmann WA, de Lanerolle P, Hozak P, Grummt I. 2004. Nuclear actin andmyosin I are required for RNA polymerase I transcription. Nat Cell Biol 6:1165-1172.
42. Sala A, La Rocca G, Burgio G, Kotova E, Di Gesu D, Collesano M, Ingrassia AM, Tulin AV, Corona DF. 2008. The nucleosome-remodeling ATPase ISWI is regulated by poly-ADP-ribosylation. PLoS Biol 6:e252.
43. Santoro R, Grummt I. 2001. Molecular mechanisms mediating methylation-dependent silencing of ribosomal gene transcription. Mol Cell 8:719-725.
44. Santoro R, Grummt I. 2005. Epigenetic mechanism of rRNA gene silencing: Temporal order of NoRC-mediated histone modification, chromatin remodeling, and DNA methylation. Mol Cell Biol 25:2539-2546.
45. Santoro R, Li J, Grummt I. 2002. The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat Genet 32:393-396.
46. Saxena A, Saffery R, Wong LH, Kalitsis P, Choo KH. 2002a. Centromere proteins Cenpa, Cenpb, and Bub3 interact with poly(ADP-ribose) polymerase-1 protein and are poly(ADP-ribosyl) ated. J Biol Chem 277:26921-26926.
47. Saxena A, Wong LH, Kalitsis P, Earle E, Shaffer LG, Choo KH. 2002b. Poly(ADP-ribose) polymerase 2 localizes to mammalian active centromeres and interacts with PARP-1, Cenpa, Cenpb and Bub3, but not Cenpc. Hum Mol Genet 11:2319-2329.
48. Schmidt A, Durgan J, Magalhaes A, Hall A. 2007. Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis. EMBO J 26:1624-1636.
49. Schoenenberger CA, Buchmeier S, Boerries M, Sutterlin R, Aebi U, Jockusch BM. 2005. Conformation-specific antibodies reveal distinct actin structures in the nucleus and the cytoplasm. J Struct Biol 152:157-168.
50. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG. 1986. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 83:4908-4912.
51. Schreiber V, Ame JC, Dolle P, Schultz I, Rinaldi B, Fraulob V,Menissier-de Murcia J, de Murcia G. 2002. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 277:23028-23036.
52. Schreiber V, Dantzer F, Ame JC, de Murcia G. 2006. Poly(ADP-ribose): Novel functions for an old molecule. Nat Rev Mol Cell Biol 7:517-528.
53. Singh NP, McCoy MT, Tice RR, Schneider EL. 1988.Asimple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
54. Smith S, de Lange T. 1999. Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J Cell Sci 112:3649-3656.
55. Smith S, de Lange T. 2000. Tankyrase promotes telomere elongation in human cells. Curr Biol 10:1299-1302.
56. Smith S, Giriat I, Schmitt A, de Lange T. 1998. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science (New York, NY) 282:1484-1487.
57. Tartier L, Spenlehauer C, Newman HC, Folkard M, Prise KM, Michael BD, Menissier-de Murcia J, de Murcia G. 2003. Local DNA damage by proton microbeam irradiation induces poly(ADP-ribose) synthesis in mammalian cells. Mutagenesis 18:411-416.
58. Tentori L, Graziani G. 2005. Chemopotentiation by PARP inhibitors in cancer therapy. Pharmacol Res 52:25-33.
59. Terashima M, Yamamori C, Shimoyama M. 1995. ADP-ribosylation of Arg28 and Arg206 on the actin molecule by chicken arginine-specific ADP- ribosyltransferase. Eur J Biochem/FEBS 231:242-249.
60. Tiozzo R, Monti D, Straface E, Capri M, Croce MA, Rainaldi G, Franceschi C, Malorni W. 1996. Antiproliferative activity of 3-aminobenzamide in A431 carcinoma cells is associated with a target effect on cytoskeleton. Biochem Biophys Res Commun 225:826-832.
61. Torrano V, Navascues J, Docquier F, Zhang R, Burke LJ, Chernukhin I, Farrar D, Leon J, Berciano MT, Renkawitz R, Klenova E, Lafarga M, Delgado MD. 2006. Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-dependent mechanism. J Cell Sci 119:1746-1759.
62. Valkov NI, Ivanova MI, Uscheva AA, Krachmarov CP. 1989. Association of actin with DNA and nuclear matrix from Guerin ascites tumour cells. Mol Cell Biochem 87:47-56.
63. Vartiainen MK, Guettler S, Larijani B, Treisman R. 2007. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science (New York, NY) 316:1749-1752.
64. Witcher M, Emerson BM. 2009. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell 34:271-284.
65. Wu JI, Crabtree GR. 2007. Cell signaling. Nuclear actin as choreographer of cell morphology and transcription. Science (New York, NY) 316:1710-1711.
66. Ye JZ, de Lange T. 2004. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex. Nat Genet 36:618-623.
67. Ye J, Zhao J, Hoffmann-Rohrer U, Grummt I. 2008. Nuclear myosin I acts in concert with polymeric actin to drive RNA polymerase I transcription. Genes Dev 22:322-330.
68. Yu W, Ginjala V, Pant V, Chernukhin I, Whitehead J, Docquier F, Farrar D, Tavoosidana G, Mukhopadhyay R, Kanduri C, Oshimura M, Feinberg AP, Lobanenkov V, Klenova E, Ohlsson R. 2004. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet 36:1105-1110.
69. Yusufzai TM, Tagami H, Nakatani Y, Felsenfeld G. 2004. CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species. Mol Cell 13:291-298.
70. Zampieri M, Passananti C, Calabrese R, Perilli M, Corbi N, De Cave F, Guastafierro T, Bacalini MG, Reale A, Amicosante G, Calabrese L, Zlatanova J,Caiafa P. 2009. Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity. PLoS ONE 4:e4717.
71. Zardo G, Caiafa P. 1998. The unmethylated state of CpG islands in mouse fibroblasts depends on the poly(ADP-ribosyl)ation process. J Biol Chem 273:16517-16520.
72. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, Crabtree GR. 1998. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95:625-636.